In urology, Firmagon (degarelix) is a pure GnRH antagonist (as opposed to GnRH agonist like leuprolide) for prostate cancer, offering the clinical advantage of immediate testosterone suppression without the initial flare associated with GnRH agonists
Correct injection technique is crucial for ensuring medication efficacy, minimizing discomfort, and reducing the risk of injection site reactions
The progression from single to dual to triple agonism represents genuine innovation, not marketing hype
The patients eventual relapse upon restarting Ozempic proves the drug is the pathological driver, perpetually compromising the VNC and preventing therapeutic gain
How to treat Injection Site Redness Injection site redness can be treated by applying a cold compress to the site or by taking a histamine blocker to help with redness, itching, and swelling
Third-party lab-tested with COAs and same-day US shipping